Copyright 2009 Medical News Today Latest Eczema / Psoriasis News From Medical News Today. http://www.medicalnewstoday.com/sections/eczema-psoriasis/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Fri, 26 Jun 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/155396.php http://www.medicalnewstoday.com/articles/155396.php Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are two of several projects being conducted through the NIH Roadmap for Medical Research as part of the Human Microbiome Project (HMP) taking place at institutions across the country. Eczema / Psoriasis Wed, 24 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/155027.php http://www.medicalnewstoday.com/articles/155027.php Ceragenix Pharmaceuticals, Inc.("Ceragenix") (OTCBB:CGXP), a medical device company focused on infectious disease and dermatology, announced that researchers at National Jewish Health, led by Dr. Donald Y. Leung and Dr. Michael Howell, in collaboration with Dr. Paul B. Eczema / Psoriasis Sat, 06 Jun 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/152844.php http://www.medicalnewstoday.com/articles/152844.php Dandruff affects the scalp and causes flakes of skin to appear - it is a common condition. Our skin cells are forever renewing themselves. When the skin cells on our scalp are renewed the old ones are pushed to the surface and out of the scalp. For a person with dandruff the renewal is faster, meaning more dead skin is shed, making the dandruff more noticeable. Dandruff can also occur if the scalp is frequently exposed to extreme temperatures. Dermatology Tue, 02 Jun 2009 08:00:00 PDT http://www.medicalnewstoday.com/articles/152296.php http://www.medicalnewstoday.com/articles/152296.php Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, has achieved yet another goal by completion of patients' enrollment in its phase II Psoriasis trial. Approximately 70 patients were enrolled to this study, randomized into 4 groups treated with 1, 2 and 4 mg of CF101 and placebo. Patients are taking the drug for 12 weeks plus 2 weeks of follow-up. The trial is being conducted in 10 sites in Israel and Europe. Eczema / Psoriasis Wed, 27 May 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/151498.php http://www.medicalnewstoday.com/articles/151498.php Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur. Eczema / Psoriasis Tue, 26 May 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/151378.php http://www.medicalnewstoday.com/articles/151378.php Researchers from the La Jolla Institute for Allergy & Immunology have pinpointed the cellular defect that increases the likelihood, among eczema sufferers, of developing eczema vaccinatum, a severe and potentially fatal reaction to the smallpox vaccine. The research, conducted in mouse models, was funded under a special research network created by the National Institutes of Health in 2004. Eczema / Psoriasis Mon, 25 May 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/151250.php http://www.medicalnewstoday.com/articles/151250.php Today sees the European launch of the first topical calcineurin inhibitor to be approved for the maintenance treatment of eczema to prevent flares and prolong flare-free intervals. PROTOPIC ointment (tacrolimus monohydrate) is already licensed to treat moderate and severe eczema (atopic dermatitis), often involving the treatment of flares as and when they occur. Eczema / Psoriasis Wed, 20 May 2009 04:00:00 PDT http://www.medicalnewstoday.com/articles/150766.php http://www.medicalnewstoday.com/articles/150766.php Many young children who get a severe skin rash develop asthma months or years later. Doctors call the progression from eczema, or atopic dermatitis, to breathing problems the atopic march.  In this week's issue of PLoS Biology, scientists at Washington University School of Medicine in St. Louis report another step taken towards understanding the process of atopic march. Eczema / Psoriasis Tue, 05 May 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/148864.php http://www.medicalnewstoday.com/articles/148864.php Abbott has announced new data showing that HUMIRA® (adalimumab) is as effective in patients with moderate to severe psoriasis at 16 weeks with or without the concurrent use of topical therapy.1 The data also confirm that patients who did not have success with other systemic treatments were able to achieve a high response with HUMIRA. Eczema / Psoriasis Sun, 03 May 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/148351.php http://www.medicalnewstoday.com/articles/148351.php Basilea Pharmaceutica Ltd. (SWISS: BSLN) (PINKSHEETS: BPMUF) announces that the Appraisal Committee of the National Institute for Health and Clinical Excellence (NICE) has developed preliminary positive recommendations with some limitations on the use of Toctino® (alitretinoin) within its licensed indication, as treatment for adults with severe chronic hand eczema that has not responded to potent topical corticosteroids. Eczema / Psoriasis Tue, 28 Apr 2009 09:00:00 PDT http://www.medicalnewstoday.com/articles/147954.php http://www.medicalnewstoday.com/articles/147954.php Scientists in the US found that giving children with chronic, severe eczema regular baths of diluted bleach reduced the clinical severity of the condition in cases with secondary bacterial infection. The study was the work of Dr Amy S Paller, the Walter J. Hamlin Professor and chair of dermatology, and professor of pediatrics, at the Northwestern University Feinberg School of Medicine, in Chicago, Illinois. Eczema / Psoriasis Tue, 28 Apr 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/147900.php http://www.medicalnewstoday.com/articles/147900.php It's best known for whitening a load of laundry. But now simple household bleach has a surprising new role: an effective treatment for kids' chronic eczema. Chronic, severe eczema can mar a childhood. The skin disorder starts with red, itchy, inflamed skin that often becomes crusty and raw from scratching. The eczema disturbs kids' sleep, alters their appearance and affects their concentration in school. Eczema / Psoriasis Tue, 21 Apr 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/146798.php http://www.medicalnewstoday.com/articles/146798.php Women with psoriasis appear to have an increased risk for developing diabetes and hypertension (high blood pressure), according to a report in the April issue of Archives of Dermatology, one of the JAMA/Archives journals. Psoriasis, a chronic inflammatory skin disease, affects between 1 percent and 3 percent of the population, according to background information in the article. Eczema / Psoriasis Thu, 16 Apr 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/146204.php http://www.medicalnewstoday.com/articles/146204.php Chronic plaque psoriasis is the most common type of psoriasis and is characterised by redness, thickness and scaling. First line management of chronic plaque psoriasis is with topical treatments, including vitamin D analogues, topical corticosteroids, tar-based preparations, dithranol, salicylic acid and topical retinoids. Eczema / Psoriasis Tue, 14 Apr 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/145953.php http://www.medicalnewstoday.com/articles/145953.php As recent research suggests a 42% rise in eczema during a five year period; could GP's be doing more? GPs are struggling to provide the quality of care for children with eczema currently recommended by two of the UK's most prestigious medical bodies: the National Institute of Health and Clinical Excellence (NICE)1 and the Primary Care Dermatology Society/British Association of Dermatologists (PCDS/BAD). Eczema / Psoriasis Tue, 14 Apr 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/145918.php http://www.medicalnewstoday.com/articles/145918.php Genentech, Inc. announced a phased voluntary withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. market. The company's decision is based on the association of Raptiva with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal disease of the central nervous system. Eczema / Psoriasis Sat, 11 Apr 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/145600.php http://www.medicalnewstoday.com/articles/145600.php Psoriatic arthritis affects about 11 percent of patients with psoriasis. Anti-tumor necrosis factor α (anti-TNFα) agents, which block signaling molecules that induce inflammation, improve the symptoms of psoriatic arthritis. Golimumab is a new human monoclonal antibody that works against TNFα and has been shown to be beneficial within two weeks of the first subcutaneous injection in a phase II rheumatoid arthritis trial. Arthritis / Rheumatology Sat, 11 Apr 2009 00:00:00 PDT http://www.medicalnewstoday.com/articles/145414.php http://www.medicalnewstoday.com/articles/145414.php Serentis, a privately owned biopharmaceutical company, announced today that it has commenced patient recruitment in a Phase II clinical trial for atopic dermatitis (AD), a type of eczema. The Phase II, double-blind, vehicle-controlled study will determine the efficacy, safety and tolerability of SRD441 in patients with AD. Eczema / Psoriasis Mon, 30 Mar 2009 03:00:00 PDT http://www.medicalnewstoday.com/articles/144162.php http://www.medicalnewstoday.com/articles/144162.php Psoriasis: The Naked Truth, a new pan-European educational programme to expose the physical and emotional impact of living with psoriasis, launches today. Eczema / Psoriasis Sat, 28 Mar 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/144041.php http://www.medicalnewstoday.com/articles/144041.php Considerably more people than previously believed are allergic to the most common fragrance ingredient used in shampoos, conditioners and soap. A thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden found that over 5% of those who underwent patch testing were allergic to the air oxidized form of the fragrance ingredient linalool. "I would suspect that about 2% of the complete population of Sweden are allergic to air oxidized linalool. Eczema / Psoriasis Fri, 27 Mar 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/143859.php http://www.medicalnewstoday.com/articles/143859.php Tracking Acute Kidney Injury Dr. Eisei Noiri and colleagues at the University of Tokyo, Japan identified a novel biomarker to monitor acute kidney injury. They present their data in the April 2009 issue of The American Journal of Pathology. Acute kidney injury may be reversible if treated promptly and appropriately. Novel biomarkers therefore need to be developed to identify injury at early time points as well as to estimate the severity of the damage. Urology / Nephrology Thu, 26 Mar 2009 02:00:00 PDT http://www.medicalnewstoday.com/articles/143690.php http://www.medicalnewstoday.com/articles/143690.php Researchers at Oregon State University have found one gene in the human body that appears to be a master regulator for skin development, in research that could help address everything from skin diseases such as eczema or psoriasis to the wrinkling of skin as people age. Inadequate or loss of expression of this gene, called CTIP2, may play a role in some skin disorders, scientists believe, and understanding the mechanisms of gene action could provide a solution to them. Dermatology Mon, 23 Mar 2009 05:00:00 PDT http://www.medicalnewstoday.com/articles/143289.php http://www.medicalnewstoday.com/articles/143289.php The number of children who have eczema has risen - one in five children are now affected by this skin condition, which is often associated with an allergy. Researchers are not yet sure what is causing this growing problem. Many people believe that certain foods are responsible, or at least make the symptoms worse. Eczema / Psoriasis Mon, 23 Mar 2009 01:00:00 PDT http://www.medicalnewstoday.com/articles/143242.php http://www.medicalnewstoday.com/articles/143242.php Avoiding foods may do more harm than good / Elimination diets can only help children who have food sensitivity The number of children who have eczema has risen - one in five children are now affected by this skin condition, which is often associated with an allergy. Researchers are not yet sure what is causing this growing problem. Many people believe that certain foods are responsible, or at least make the symptoms worse. Eczema / Psoriasis Tue, 17 Mar 2009 06:00:00 PDT http://www.medicalnewstoday.com/articles/142560.php http://www.medicalnewstoday.com/articles/142560.php Low-dose acitretin (a drug used to treat skin psoriasis) therapy appears to reduce nail psoriasis symptoms, according to a report in the March issue of Archives of Dermatology, one of the JAMA/Archives journals. Eczema / Psoriasis